THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM
Total 13F shares
112,516,421
Share change
+16,923,762
Total reported value
$680,746,484
Put/Call ratio
22%
Price per share
$6.05
Number of holders
93
Value change
+$103,006,656
Number of buys
61
Number of sells
31

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q1 2015

As of 31 Mar 2015, THERAPEUTICSMD INC - COM (TXMD) was held by 93 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 112,516,421 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, Bank of New York Mellon Corp, FRANKLIN RESOURCES INC, GILDER GAGNON HOWE & CO LLC, BlackRock Fund Advisors, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, STATE STREET CORP, and MASSACHUSETTS FINANCIAL SERVICES CO /MA/. This page lists 93 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.